Glucagon – the new ‘insulin’ in the pathophysiology of diabetes

  title={Glucagon – the new ‘insulin’ in the pathophysiology of diabetes},
  author={L. Farhy and A. McCall},
  journal={Current Opinion in Clinical Nutrition and Metabolic Care},
  • L. Farhy, A. McCall
  • Published 2015
  • Medicine
  • Current Opinion in Clinical Nutrition and Metabolic Care
  • Purpose of reviewAutoimmune destruction of the &bgr; cells is considered the key abnormality in type 1 diabetes mellitus and insulin replacement the primary therapeutic strategy. However, a lack of insulin is accompanied by disturbances in glucagon release, which is excessive postprandially, but insufficient during hypoglycaemia. In addition, replacing insulin alone appears insufficient for adequate glucose control. This review focuses on the growing body of evidence that glucagon abnormalities… CONTINUE READING
    9 Citations

    Topics from this paper.

    The New Biology and Pharmacology of Glucagon.
    • 113
    Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
    • 37
    • PDF
    A Comprehensive Review of Novel Drug–Disease Models in Diabetes Drug Development
    • 8
    Role of Glucagon in Automated Insulin Delivery.
    • 1
    Tripartite cell networks for glucose homeostasis.
    • 2
    Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice
    • 9
    • PDF
    Replacing Pumps with Light Controlled Insulin Delivery
    • 1


    Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.
    • 466
    • PDF
    Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells
    • 61
    • PDF
    Paracrinology of islets and the paracrinopathy of diabetes
    • R. Unger, L. Orci
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences
    • 2010
    • 195
    • PDF
    Glucagon regulates orexin A secretion in humans and rodents
    • 16